Non-invasive Estimation of CSF Pressure Using MRI in Patients With Spontaneous Intracranial Hypotension
1 other identifier
interventional
5
1 country
1
Brief Summary
The purpose of this study is to estimate the intracranial pressure (ICP, the pressure in your head) in subjects with intracranial hypotension (a condition caused by leakage of the fluid that surrounds your brain and spine) using non-invasive magnetic resonance imaging (MRI) techniques, and to determine whether changes in estimated ICP are seen after treatment of this condition.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2017
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 1, 2017
CompletedFirst Posted
Study publicly available on registry
February 2, 2017
CompletedStudy Start
First participant enrolled
September 14, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 25, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
October 26, 2019
CompletedResults Posted
Study results publicly available
July 28, 2020
CompletedJuly 28, 2020
July 1, 2020
2.1 years
February 1, 2017
July 10, 2020
July 10, 2020
Conditions
Outcome Measures
Primary Outcomes (2)
Intracranial Pressure Measurements Estimated by the MRICP Technique.
The measurement of the momentary differences between the volumes of blood and CSF entering and leaving the cranium during the cardiac cycle provides an estimate of the intracranial volume change, and the pressure difference is estimated using the derivative of the CSF velocities.
During scan, approximately 30 minutes
Cerebro Spinal Fluid Pressure Measured by Lumbar Puncture
The CSF pressure measured at lumbar puncture (LP), is 100-180 mm of H2O (8-15 mm Hg) with the patient lying on the side and 200-300 mm with the patient sitting up.
During lumbar procedure, up to 2 hours
Secondary Outcomes (3)
Change in Intracranial Pressure Estimated With MR Technique
Baseline, 24 hours
Change in Caliber to the Transverse Venous Sinus Caliber
Baseline, 24 hours
Change in Flow Velocity Through the Transverse Dural Venous Sinus
Baseline, 24 hours
Study Arms (1)
MRICP method
EXPERIMENTALMRI sequences have been developed that may be able to estimate ICP in a non-invasive fashion.6-10 The MRI-based method for measurement of ICP (MRICP method) is based on basic principles of the cranio-spinal CSF physiology: The mono-exponential relationship between intracranial volume and pressure leads to a linear relationship between elastance (i.e., the derivative of pressure with respect to volume) and pressure.
Interventions
MRI sequences have been developed that may be able to estimate intracranial pressure in a non-invasive fashion
Lumbar puncture according to the standard-of-care treatment plan.
Epidural patching will be performed to the standard-of -care treatment plan
Eligibility Criteria
You may qualify if:
- Known diagnosis of intracranial hypotension, established by the following criteria: the presence of orthostatic headache, and one or more of the following criteria: prior CSF opening pressure ≤6 cmH20, demonstration of an active spinal CSF leak on prior spine imaging, or cranial MRI changes of intracranial hypotension.15
- Ability to provide informed consent.
- Expected ability to complete standard-of-care procedures (lumbar puncture and epidural patching)
You may not qualify if:
- Known contraindication to MRI (pacemaker, MRI incompatible hardware, etc.)
- Severe claustrophobia or other condition requiring the need for anxiolysis, sedation, or any other medication for MRI scanning
- Inability or expected inability to complete study interventions as scheduled
- Any known contraindication to standard-of-care procedures (e.g. coagulopathy, allergic reaction to required medication, lack of vascular access, etc.)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke Universitylead
- University of Miamicollaborator
Study Sites (1)
Duke University
Durham, North Carolina, 27710, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Research Coordiantor
- Organization
- Duke University Dept of Radiology
Study Officials
- PRINCIPAL INVESTIGATOR
Peter Kranz, MD
Duke University
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 1, 2017
First Posted
February 2, 2017
Study Start
September 14, 2017
Primary Completion
October 25, 2019
Study Completion
October 26, 2019
Last Updated
July 28, 2020
Results First Posted
July 28, 2020
Record last verified: 2020-07